إعلان
إعلان
RGNX
REGENXBIO Inc.
14.57
USDبرعاية
-0.43
-2.85%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
15.02
+0.44
+3.04%
تقارير أرباح RGNX
النسبة الإيجابية المفاجئة
RGNX تفوق 16 من 40 آخر التقديرات.
40%
التقرير التالي
بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$50.48M
/-$0.85
التغير الضمني من Q3 25 (Revenue/ EPS)
+69.79%
/-29.17%
التغير الضمني من Q4 24 (Revenue/ EPS)
+137.97%
/-15.84%
REGENXBIO Inc. earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, RGNX reported earnings of -1.20 USD per share (EPS) for Q3 25, beating the estimate of -1.33 USD, resulting in a 9.88% surprise. Revenue reached 29.73 مليون, compared to an expected 24.61 مليون, with a 20.83% difference. The market reacted with a -3.79% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 المحللين forecast an EPS of -0.85 USD, with revenue projected to reach 50.48 مليون USD, implying an نقصان of -29.17% EPS, and زيادة of 69.79% in Revenue from the last quarter.
الأسئلة الشائعة
What were REGENXBIO Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, REGENXBIO Inc. reported EPS of -$1.20, beating estimates by 9.88%, and revenue of $29.73M, 20.83% above expectations.
How did the market react to REGENXBIO Inc.'s Q3 2025 earnings?
The stock price moved down -3.79%, changed from $11.61 before the earnings release to $11.17 the day after.
When is REGENXBIO Inc. expected to report next?
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
What are the forecasts for REGENXBIO Inc.'s next earnings report?
Based on 14
المحللين, REGENXBIO Inc. is expected to report EPS of -$0.85 and revenue of $50.48M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان